Fasudil alleviates brain damage in rats after carbon monoxide poisoning through regulating neurite outgrowth inhibitor/oligodendrocytemyelin glycoprotein signalling pathway. | Canada Hyperbarics Skip to main content
Clinical Study Basic & clinical pharmacology & toxicology 2019

Fasudil alleviates brain damage in rats after carbon monoxide poisoning through regulating neurite outgrowth inhibitor/oligodendrocytemyelin glycoprotein signalling pathway.

Wang L, Xu J, Guo D, Zhou X, Jiang W, Wang J, et al. — Basic & clinical pharmacology & toxicology, 2019

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated the effects of Fasudil on brain damage in rats exposed to carbon monoxide poisoning, with some rats receiving additional daily Fasudil injections alongside hyperbaric oxygen therapy.

What They Found

The carbon monoxide (CO) poisoning group exhibited significantly prolonged escape latency, indicating impaired neurological function. Although specific numerical improvements were not fully detailed in the provided abstract, the study's title indicates that Fasudil treatment alleviated brain damage and regulated the neurite outgrowth inhibitor/oligodendrocytemyelin glycoprotein signalling pathway.

What This Means for Canadian Patients

While this study was conducted in rats, it suggests Fasudil could be a potential new therapeutic agent to mitigate brain damage following carbon monoxide poisoning. Further research is needed to determine if these findings translate to human patients and could offer improved outcomes for Canadians suffering from CO poisoning.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.

Study Limitations

A primary limitation is that this was an animal study, and the full details of the methods and results were not available due to the truncated abstract.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Carbon Monoxide Poisoning
Source Pubmed
PubMed ID 30916885
Year Published 2019
Journal Basic & clinical pharmacology & toxicology
MeSH Terms 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Brain; Carbon Monoxide; Carbon Monoxide Poisoning; Disease Models, Animal; Drug Evaluation, Preclinical; GPI-Linked Proteins; Humans; Male; Myelin Proteins; Nogo Proteins; Protein Kinase Inhibitors; Rats; Signal Transduction

Cite This Study

Share

Find a Canadian Clinic Treating Carbon Monoxide Poisoning

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.